Nalaganje...
Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
BACKGROUND: In our previous SMC NB-2004 study of patients with high-risk neuroblastomas, which incorporated total-body irradiation (TBI) with second high-dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT), the survival rate was encouraging; however, short- and long-term toxic...
Shranjeno v:
| izdano v: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5432997/ https://ncbi.nlm.nih.gov/pubmed/28511709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0477-0 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|